Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Org 50081 (esmirtazapine) for vasomotor symptoms of menopause
2004-000472-14Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of esmirtazapine in menopause (5 arms), sponsored by Organon & Co. Primary endpoint: Mean change from baseline in average daily frequency of moderate to severe vasomotor symptoms. Started Sep 2004; status: completed.
02
Drugs
esmirtazapine
03
Conditions
menopause
Beyond the preview
Go deeper on 2004-000472-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000472-14.